Key result
Maternal self-administration of nimesulide at 39 weeks of gestation caused premature ductal constriction and fetal tachycardia within 24 hours in a single case.
Why the study?
Does maternal nimesulide use cause premature ductal constriction in a term fetus?
Case Report (n=1)
Does maternal nimesulide use cause premature ductal constriction in a term fetus?
Maternal use of nimesulide at term can rapidly cause premature ductal constriction and fetal heart rate abnormalities.
Answers are grounded in this paper and cite their sources.
May warrant avoiding nimesulide near term; leaves open generalizability beyond this single case.
OBJECTIVE: To describe clinical findings in a case of premature ductal constriction associated with maternal use of nimesulide, a cyclo-oxygenase type-2 inhibitor. METHODS: Case report. RESULTS: A mother self-administered nimesulide at 39 weeks of gestation due to lower back pain. Less than 24 h later premature ductal constriction was diagnosed by echocardiography following a suspicious fetal heart rate recording with baseline tachycardia and absent accelerations. CONCLUSION: In a term pregnancy, nimesulide administration can rapidly cause premature ductal constriction. This condition may induce abnormalities in the fetal heart rate trace.
No takes yet. Share an insight, caveat, or question.
Prefumo et al. (2008) conducted a case report in Premature ductal constriction (n=1). Nimesulide was evaluated on Premature ductal constriction. Maternal self-administration of nimesulide at 39 weeks of gestation caused premature ductal constriction and fetal tachycardia within 24 hours in a single case.
Synapse has enriched 10 related papers. Consider them for comparative context: